Wed, November 9, 2011
[ Wed, Nov 09th 2011 ] - Market Wire
NuVasive to Participate in the Lazard Health Care Conference
[ Wed, Nov 09th 2011 ] - Market Wire
Scripps Health and The Medicines Company Announce .. te Breaking BRIDGE Trial Results Presented at TCT
[ Wed, Nov 09th 2011 ] - Market Wire
ProMetic to Hold Third Quarter 2011 Financial Results Conference Call and Webcast
[ Wed, Nov 09th 2011 ] - Market Wire
CE Mark for Verisante Aura(TM) Opens Doors to Massive European Market
[ Wed, Nov 09th 2011 ] - Market Wire
BIOLASE to Present at Lazard Capital Markets Healthcare Conference
[ Wed, Nov 09th 2011 ] - Market Wire
ISS Proxy Advisory Services Recommends Poniard Sh .. 's Proposed Merger With ALLOZYNE and Reverse Stoc
[ Wed, Nov 09th 2011 ] - Market Wire
Unigene Announces Positive Top-Line Results of Ph .. Treatment of Osteoporosis in Postmenopausal Women
[ Wed, Nov 09th 2011 ] - Market Wire
ProPhase Labs Reports Third Quarter 2011 Results
[ Wed, Nov 09th 2011 ] - Market Wire
Mylan to Acquire Pfizer Respiratory Delivery Platform
[ Wed, Nov 09th 2011 ] - Market Wire
GenVec Reports Third Quarter 2011 Financial Results
[ Wed, Nov 09th 2011 ] - Market Wire
LCA-Vision to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
[ Wed, Nov 09th 2011 ] - Market Wire
Uroplasty Announces Issuance of New Apparatus Pat .. r the Urgent PC Neuromodulation System Stimulator
[ Wed, Nov 09th 2011 ] - Market Wire
JCM Passes Internal Quality Assessment for Azithromycin API Production
[ Wed, Nov 09th 2011 ] - Market Wire
LX2931 Phase 2 Data to be Presented at the American College of Rheumatology Conference
[ Wed, Nov 09th 2011 ] - Market Wire
Dako Enters New Collaboration With Bristol-Myers Squibb on Pharmacodiagnostics
Tue, November 8, 2011
[ Tue, Nov 08th 2011 ] - Market Wire
Allon Therapeutics Releases Q3 Operating Results and Provides Corporate Update
[ Tue, Nov 08th 2011 ] - Market Wire
Boston Scientific Platinum Chromium IONa" Stent D .. tes Positive Outcomes in PERSEUS Clinical Program
[ Tue, Nov 08th 2011 ] - Market Wire
Daxor Corporation Announces Payment of a Fourth Quarter Dividend
[ Tue, Nov 08th 2011 ] - Market Wire
Acquisition Spotlight Shines on Hepatitis C Drug Developers
[ Tue, Nov 08th 2011 ] - Market Wire
Discovery Labs Releases New AFECTAIRa" Performanc .. can Association for Respiratory Care Annual Meeti
[ Tue, Nov 08th 2011 ] - Market Wire
Psychemedics erhlt internationale ISO/IEC 17025-Akkreditierung
[ Tue, Nov 08th 2011 ] - Market Wire
PROLOR Biotech to Present at Lazard Capital Markets 8th Annual Healthcare Conference
[ Tue, Nov 08th 2011 ] - Market Wire
BioSpecifics Technologies Corp. Reports Third Quarter 2011 Financial Results
[ Tue, Nov 08th 2011 ] - Market Wire
CONMED Corporation to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
[ Tue, Nov 08th 2011 ] - Market Wire
Given Imaging to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
[ Tue, Nov 08th 2011 ] - Market Wire
Uroplasty to Present at Two Upcoming Conferences
[ Tue, Nov 08th 2011 ] - Market Wire
Omeros Corporation Reports Third Quarter 2011 Financial Results
[ Tue, Nov 08th 2011 ] - Market Wire
PDL BioPharma to Present at Lazard Capital Markets 8th Annual Healthcare Conference
[ Tue, Nov 08th 2011 ] - Market Wire
Lilly and Amylin Mutually Agree to End Diabetes A .. and Transition Exenatide Responsibility to Amylin
[ Tue, Nov 08th 2011 ] - Market Wire
Abbott Reports Five-Year Data for HUMIRA (Adalimumab) in Ankylosing Spondylitis
Mon, November 7, 2011
[ Mon, Nov 07th 2011 ] - Market Wire
Cantel Medical Corp. to Present at the Stephens Inc. Fall Investment Conference
[ Mon, Nov 07th 2011 ] - Market Wire
Medivation, American International Group, Tech Data, Apple and Google
[ Mon, Nov 07th 2011 ] - Market Wire
Critical Stock Alerts for Johnson & Johnson, RF M .. rox, Wells Fargo, Health Care REIT & UnitedHealth
[ Mon, Nov 07th 2011 ] - Market Wire
Southwest Healthcare System Regulatory Update
[ Mon, Nov 07th 2011 ] - Market Wire
Professional Outlook, Will EU's Deal Hold the Mar .. orda Therapeutics Inc. and BioMarin Pharmaceutica
[ Mon, Nov 07th 2011 ] - Market Wire
Neogen Develops Quicker Test for Yeast and Mold
[ Mon, Nov 07th 2011 ] - Market Wire
Comprehensive Care Corporation Names Robert R. Kulbick New President
[ Mon, Nov 07th 2011 ] - Market Wire
Glass Lewis Recommends Poniard Shareholders Vote .. osed Merger With ALLOZYNE and Reverse Stock Split
[ Mon, Nov 07th 2011 ] - Market Wire
30 a.m. ET
[ Mon, Nov 07th 2011 ] - Market Wire
Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011
[ Mon, Nov 07th 2011 ] - Market Wire
Top 5 Global Pharmaceutical Company Selects NewCardio's QTinno for Phase I Drug Safety Trial
[ Mon, Nov 07th 2011 ] - Market Wire
Implant Sciences Announces New Sales in Japan and .. uclear Power Plant Protection and Law Enforcement
[ Mon, Nov 07th 2011 ] - Market Wire
Syneron's New ePrimea" Device Featured on The Doctors Show as the Latest Super Age Eraser
[ Mon, Nov 07th 2011 ] - Market Wire
PAREXEL International to Present at Lazard Capita .. care Conference and Citi Small/Mid Cap Conference
[ Mon, Nov 07th 2011 ] - Market Wire
Abbott Presents HUMIRA (Adalimumab) Phase 3 Study .. h Active Non-Radiographic Axial Spondyloarthritis
Sun, November 6, 2011
[ Sun, Nov 06th 2011 ] - Market Wire
Galapagos to present results for selective JAK1 i .. rheumatoid arthritis patients on 22 November 2011
[ Sun, Nov 06th 2011 ] - Market Wire
Helix BioPharma Corp. Announces Meeting of Shareholders
[ Sun, Nov 06th 2011 ] - Market Wire
Abbott Announces New Long-Term Data Evaluating Us .. Patients with Long-Standing Moderate to Severe Rh
[ Sun, Nov 06th 2011 ] - Market Wire
Daten des ersten Teils einer Phase-2-Studie unter .. fr die hufigste Form von Mukoviszidose (F508del),
Sat, November 5, 2011
[ Sat, Nov 05th 2011 ] - Market Wire
Prolia (denosumab) Open-Label Extension Trial Sho .. e Mineral Density Over Six Years With Similar Saf
[ Sat, Nov 05th 2011 ] - Market Wire
Treatment With Enbrel (etanercept) Shows Signific .. nefits in Rheumatoid Arthritis (RA) Patients With
[ Sat, Nov 05th 2011 ] - Market Wire
Savient Pharmaceuticals Announces New Data Surrou .. t of Refractory Chronic Gout at the American Coll
[ Sat, Nov 05th 2011 ] - Market Wire
Teleflex to Focus on Innovative Products and Solu .. American Association of Respiratory Care Congress
[ Sat, Nov 05th 2011 ] - Market Wire
Kinetic Concepts, Inc. Completes Merger with Apax Consortium
[ Sat, Nov 05th 2011 ] - Market Wire
CareFusion Announces New Ventilation Solution to .. ls Provide Improved Patient Care and Reduce Costs
[ Sat, Nov 05th 2011 ] - Market Wire
Health Net Wins Two Awards in 2011 National Health Information Awards Program
[ Sat, Nov 05th 2011 ] - Market Wire
BioMimetic Therapeutics, Inc. to Report 2011 Third Quarter Financial Results on November 8
[ Sat, Nov 05th 2011 ] - Market Wire
Interim Data for Merck's VICTRELISTM (boceprevir) .. ents with Chronic Hepatitis C Genotype 1 to be Pr
[ Sat, Nov 05th 2011 ] - Market Wire
Gilead Announces Positive Five-Year Data Showing .. rosis and Cirrhosis Caused by Chronic Hepatitis B
[ Sat, Nov 05th 2011 ] - Market Wire
Interim Data for Merck';;s VICTREL .. ll Responder Patients with Chronic Hepatitis C Ge
[ Sat, Nov 05th 2011 ] - Market Wire
Interim Data for Merck';;;s VIC .. or Null Responder Patients with Chronic Hepatitis
[ Sat, Nov 05th 2011 ] - Market Wire
Interim Data for Merck';;;;s .. Prior Null Responder Patients with Chronic Hepati
[ Sat, Nov 05th 2011 ] - Market Wire
Medtronicas Unmatched Portfolio of Cardiovascular .. ices Features Prominently on Program for TCT 2011
[ Sat, Nov 05th 2011 ] - Market Wire
Bull & Lifshitz, LLP Announces Investigation of Adolor Corporation
Fri, November 4, 2011
[ Fri, Nov 04th 2011 ] - Market Wire
iBio, Inc. Receives Notice from NYSE Amex Staff t .. ntly is Below Certain Continued Listing Standards
[ Fri, Nov 04th 2011 ] - Market Wire
CML HealthCare Inc. Announces Release Date for 2011 Third Quarter Financial Results
[ Fri, Nov 04th 2011 ] - Market Wire
URBAN AG Names Billy V. Ray Jr. President and Member of Board of Directors
[ Fri, Nov 04th 2011 ] - Market Wire
CML HealthCare Inc. Celebrates Medical Radiation Technologists Week-November 6-12, 2011
[ Fri, Nov 04th 2011 ] - Market Wire
KCI e consrcio dirigidos pela Apax Partners anunciam concluso das conversaes sobre gesto executiva
[ Fri, Nov 04th 2011 ] - Market Wire
Acorda Therapeutics Reports Third Quarter 2011 Financial Results
[ Fri, Nov 04th 2011 ] - Market Wire
Santarus and Pharming Announce Presentation of Re .. Analyses of Data from Clinical Studies of RHUCIN
[ Fri, Nov 04th 2011 ] - Market Wire
Ardea Biosciences Reports Recent Accomplishments, .. g Events and Third Quarter 2011 Financial Results
[ Fri, Nov 04th 2011 ] - Market Wire
Cancer Treatments From Dendreon and Cell Therapeutics May Not Be as Lucrative as Hoped
[ Fri, Nov 04th 2011 ] - Market Wire
Highly Anticipated Drugs From BioSante and AEterna Zentaris May Not Be as Lucrative as Expected
[ Fri, Nov 04th 2011 ] - Market Wire
Equity Research on Raptor Pharmaceuticals Corp. a .. Mixed Results for Diagnostic Substances Industry
[ Fri, Nov 04th 2011 ] - Market Wire
For The Earth Corporation Grows Globally
[ Fri, Nov 04th 2011 ] - Market Wire
Novadaq Reports Third Quarter 2011 Financial Results
[ Fri, Nov 04th 2011 ] - Market Wire
Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility
[ Fri, Nov 04th 2011 ] - Market Wire
Quest Diagnostics anuncia el lanzamiento del test .. Direct para gripe y virus respiratorios en Europa
Thu, November 3, 2011
[ Thu, Nov 03rd 2011 ] - Market Wire
Aoxing Pharmaceutical Company Announces Special Funding From Hebei Province in China
[ Thu, Nov 03rd 2011 ] - Market Wire
Humana Inc. to Present at the Credit Suisse 2011 Healthcare Conference
[ Thu, Nov 03rd 2011 ] - Market Wire
Sirona Biochem Announces New Grant of Stock Options
[ Thu, Nov 03rd 2011 ] - Market Wire
MSA Declares Fourth Quarter Dividend
[ Thu, Nov 03rd 2011 ] - Market Wire
Threshold Pharmaceuticals Reports Third Quarter 2011 Financial and Operational Results
[ Thu, Nov 03rd 2011 ] - Market Wire
AVI BioPharma Announces Third Quarter 2011 Financial Results and Recent Corporate Developments
[ Thu, Nov 03rd 2011 ] - Market Wire
SpectraScience to Hold Business Update Conference Call on November 10, 2011
[ Thu, Nov 03rd 2011 ] - Market Wire
BioElectronics' Study on Postoperative Pain Reduc .. ublished in the Aesthetic Plastic Surgery Journal
[ Thu, Nov 03rd 2011 ] - Market Wire
MethylGene Reports Third Quarter 2011 Financial Results and Provides Clinical Update
[ Thu, Nov 03rd 2011 ] - Market Wire
Dynavax Prices Public Offering of Common Stock
[ Thu, Nov 03rd 2011 ] - Market Wire
SecureAlert, Inc. and Commonwealth of Puerto Rico .. Violence With Focus on Family Safety and Real-Tim
[ Thu, Nov 03rd 2011 ] - Market Wire
Celsion Corporation to Hold Third Quarter 2011 Fi .. ts Conference Call on Thursday, November 10, 2011
[ Thu, Nov 03rd 2011 ] - Market Wire
FONAR Reports Error in Reports Regarding Its Common Stock
[ Thu, Nov 03rd 2011 ] - Market Wire
Medivation and Astellas Announce Positive Surviva .. of Phase 3 AFFIRM Trial of MDV3100 in Men With Ad
[ Thu, Nov 03rd 2011 ] - Market Wire
Kraig Biocraft Laboratories, Inc. Signs Spider Si .. cense Agreement With the University of Notre Dame
Wed, November 2, 2011
[ Wed, Nov 02nd 2011 ] - Market Wire
ING 3Q11 underlying net profit increases to EUR 1,285 million
[ Wed, Nov 02nd 2011 ] - Market Wire
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results
[ Wed, Nov 02nd 2011 ] - Market Wire
Dynavax Announces Proposed Public Offering of Common Stock
[ Wed, Nov 02nd 2011 ] - Market Wire
Stellar Biotechnologies to Submit Documents for Registration of Shares in the U.S.
[ Wed, Nov 02nd 2011 ] - Market Wire
BIOLASE to Present at WJB Capital Group's Laser Company -- Management Access Event
[ Wed, Nov 02nd 2011 ] - Market Wire
NuPathe Appoints Bart J. Dunn as Vice President, Corporate Development &;; Licensing
[ Wed, Nov 02nd 2011 ] - Market Wire
ProPhase Labs to Release Third Quarter Results on Wednesday, November 9th
[ Wed, Nov 02nd 2011 ] - Market Wire
Faster FDA Drug Reviews Should Benefit Cardium Therapeutics and CytRx Corporation
[ Wed, Nov 02nd 2011 ] - Market Wire
Faster FDA Review Process Bodes Well for NPS Pharmaceuticals and Cel-Sci Corp
[ Wed, Nov 02nd 2011 ] - Market Wire
IBEX Reports Q4 and Fiscal 2011 Results
[ Wed, Nov 02nd 2011 ] - Market Wire
New Studies Show GERD Is Best Assessed Off PPI Therapy
[ Wed, Nov 02nd 2011 ] - Market Wire
MELA Sciences Announces FDA Approval for MelaFind(R)
[ Wed, Nov 02nd 2011 ] - Market Wire
Medivation Announces Third Quarter Financial Resu .. ts Teleconference and Webcast on November 9, 2011
[ Wed, Nov 02nd 2011 ] - Market Wire
Implant Sciences Signs Cooperative Research && .. nt With TSL S&;;T, a Directorate of the
[ Wed, Nov 02nd 2011 ] - Market Wire
Threshold Pharmaceuticals Appoints Nipun Davar as .. t of Pharmaceutical Development and Manufacturing
Tue, November 1, 2011
[ Tue, Nov 01st 2011 ] - Market Wire
Solta and Medicis Announce Close of Agreement for LIPOSONIX
[ Tue, Nov 01st 2011 ] - Market Wire
ISTA Pharmaceuticals Reports Third Quarter 2011 Financial Results
[ Tue, Nov 01st 2011 ] - Market Wire
Critical Outcome Technologies Inc. to Deliver Pod .. on on COTI-2 at Influential Scientific Conference
[ Tue, Nov 01st 2011 ] - Market Wire
Syneron Sets New Facial Rejuvenation Standard Wit .. t the American Society of Dermatologic Surgery Co
[ Tue, Nov 01st 2011 ] - Market Wire
Immunovaccine to Report Q3 2011 Financial Results and Conference Call
[ Tue, Nov 01st 2011 ] - Market Wire
RepliCel Provides Update on First-in-man Clinical Trials and Recent Corporate Activity
[ Tue, Nov 01st 2011 ] - Market Wire
Equity Research on Pharmaceutical Product Develop .. cs Inc. - Acquisitions and Privatizations Dominat
[ Tue, Nov 01st 2011 ] - Market Wire
Aeolus Pharmaceuticals Announces Positive Results .. Neupogen(R) as Combination Therapy for Treatment
[ Tue, Nov 01st 2011 ] - Market Wire
Cytokinetics Announces Initiation of Second Cohor .. l Trial Evaluating CK-2017357 in Patients With AL
[ Tue, Nov 01st 2011 ] - Market Wire
VentriPoint Commences Clinical Studies of Pulmona .. ension Application of Right Heart Analysis System
[ Tue, Nov 01st 2011 ] - Market Wire
Imaging3, Inc. FDA 510(k) Protocol Meeting Update
[ Tue, Nov 01st 2011 ] - Market Wire
SciClone Pharmaceuticals to Report Third Quarter 2011 Financial Results on November 8
[ Tue, Nov 01st 2011 ] - Market Wire
Implant Sciences' Explosives Trace Detector Deployed at Middle East Embassy
[ Tue, Nov 01st 2011 ] - Market Wire
Reflect Scientific, Inc. Strengthens Liquid Nitrogen Cooling Intellectual Property Position
[ Tue, Nov 01st 2011 ] - Market Wire
Threshold Pharmaceuticals to Present at the Lazard Healthcare Conference
Mon, October 31, 2011
[ Mon, Oct 31st 2011 ] - Market Wire
Covance Central Laboratory Services Ranks #1 in Global Investigator Satisfaction Survey
[ Mon, Oct 31st 2011 ] - Market Wire
Exelixis to Initiate Cabozantinib a306 Trial with Pain Endpoint in mCRPC
[ Mon, Oct 31st 2011 ] - Market Wire
SRI/Surgical Express Third Quarter 2011 Conference Call
[ Mon, Oct 31st 2011 ] - Market Wire
Merck Announces Dates for R&D and Business Briefi .. and Fourth-Quarter 2011 Sales and Earnings Report
[ Mon, Oct 31st 2011 ] - Market Wire
NPS Pharmaceuticals to Host Conference Call to Di .. can College of Gastroenterology Annual Scientific
[ Mon, Oct 31st 2011 ] - Market Wire
Medtronic Receives First FDA Approval of Cobalt C .. Expandable Stent to Treat Narrowed Iliac Arteries
[ Mon, Oct 31st 2011 ] - Market Wire
PharmStar to Pursue SEC Fully-Reporting Status
[ Mon, Oct 31st 2011 ] - Market Wire
Teva Presents New Data on QNASLa" at the 2011 Ame .. of Allergy, Asthma and Immunology Annual Meeting
[ Mon, Oct 31st 2011 ] - Market Wire
CytRx Announces Favorable Initial Results from it .. nical Trial in Patients with Soft Tissue Sarcomas
[ Mon, Oct 31st 2011 ] - Market Wire
Health Net Named to USO-Metroas Circle of Stars
[ Mon, Oct 31st 2011 ] - Market Wire
Trimel Initiates Dosing in Phase III Trial of CompleoTRT in Male Hypogonadal Patients
[ Mon, Oct 31st 2011 ] - Market Wire
Given Imaging Announces New Studies Validate Use .. llCam SB(R) to Detect and Monitor Crohn's Disease
[ Mon, Oct 31st 2011 ] - Market Wire
Teleflex Launches New Website for Teleflex ISIS HVTa", the First Comprehensive Endotracheal Tube
[ Mon, Oct 31st 2011 ] - Market Wire
Illumina Names Dr. Daniel S. Grosu Chief Medical Officer
[ Mon, Oct 31st 2011 ] - Market Wire
Winner Medical Ranked High by CNTAC
Sat, October 29, 2011
[ Sat, Oct 29th 2011 ] - Market Wire
Gilead presenta solicitud de nuevo frmaco a la FD .. "Quad" de nica pastilla una vez al da para el VIH
Fri, October 28, 2011
[ Fri, Oct 28th 2011 ] - Market Wire
Almost Family, Inc. to Report Third Quarter 2011 Financial Results on November 2, 2011
[ Fri, Oct 28th 2011 ] - Market Wire
Watson to Present at the 2011 Annual Credit Suisse Health Care Conference
[ Fri, Oct 28th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company
[ Fri, Oct 28th 2011 ] - Market Wire
Ergoresearch Ltd Reports Growing Sales of 9.0% fo .. 30, 2011. Earnings Before Tax for the Period Amou
[ Fri, Oct 28th 2011 ] - Market Wire
Medtronic Receives IDE Approval to Conduct ASPIRE .. sulin Pump with Low Glucose Suspend for US Market
[ Fri, Oct 28th 2011 ] - Market Wire
Advaxis Receives Additional Financing
[ Fri, Oct 28th 2011 ] - Market Wire
The Medicines Company and Daiichi Sankyo Announce Angiox(R) (Bivalirudin) Co-Promotion for Germany
[ Fri, Oct 28th 2011 ] - Market Wire
What's Ahead: Today's Economic Outlook - Equity R .. Mylan Inc. and Medicis Pharmaceutical Corporation
[ Fri, Oct 28th 2011 ] - Market Wire
Egan-Jones Recommends Poniard Shareholders Vote " .. osed Merger With ALLOZYNE and Reverse Stock Split
[ Fri, Oct 28th 2011 ] - Market Wire
Analyst Research on Sequenom Inc. and Life Techno .. Companies Succeeding in Bringing Products to the
[ Fri, Oct 28th 2011 ] - Market Wire
Pfizer Completes Acquisition Of Icagen
[ Fri, Oct 28th 2011 ] - Market Wire
Gilead deposita una domanda di approvazione di nu .. per gli Alimenti e i Medicinali statunitense (Foo
[ Fri, Oct 28th 2011 ] - Market Wire
Salix Pharmaceuticals Previews American College of Gastroenterology 2011
[ Fri, Oct 28th 2011 ] - Market Wire
Gilead stellt Zulassungsantrag bei der FDA fr neu .. r HIV-Therapie mit tglich einer einzigen Tablette
[ Fri, Oct 28th 2011 ] - Market Wire
Threshold Pharmaceuticals Reports Further Promising Data With TH-302 in Soft Tissue Sarcoma
Thu, October 27, 2011
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec en Portola Pharmaceuticals kondigen i .. n voor oraal syk-remmerprogramma gericht op auto-
[ Thu, Oct 27th 2011 ] - Market Wire
Crystal Research Associates, LLC Issues Executive .. al Overview (EIO) on Adamis Pharmaceuticals Corp.
[ Thu, Oct 27th 2011 ] - Market Wire
FMX Ventures Inc. and Tolima Gold Corp. Announce .. or and Commencement of Private Placement Offering
[ Thu, Oct 27th 2011 ] - Market Wire
Cannabis Science Releases First Cannabis-Extract- .. Now at Cannabis Therapeutics, 957 E. Fillmore St,
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec e Portola Pharmaceuticals hanno annun .. ale per Oral Syk, il programma inibitore specific
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec et Portola Pharmaceuticals annoncent .. ns le cadre daun programme dainhibiteur oral de l
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec und Portola Pharmaceuticals verknden .. rogramm fr den oral verabreichten SYK-Inhibitor b
[ Thu, Oct 27th 2011 ] - Market Wire
Health Net Federal Services Launches Mobile Site .. he-Go Access to Health Care for Military Families
[ Thu, Oct 27th 2011 ] - Market Wire
Human Genome Sciences and Xoma Fall Victim to Volatile Nature of Biotech Sector
[ Thu, Oct 27th 2011 ] - Market Wire
PharmaGap Sets Time for in Vivo Tests
[ Thu, Oct 27th 2011 ] - Market Wire
Dynavax Phase 3 Data in Chronic Kidney Disease De .. rates Superiority of HEPLISAV(TM) vs Engerix-B(R)
[ Thu, Oct 27th 2011 ] - Market Wire
Implant Sciences Explosives Detection Technology Protects Major European Bank
[ Thu, Oct 27th 2011 ] - Market Wire
Acorda Therapeutics to Host Conference Call to Di .. uarter 2011 Financial Results on November 4, 2011
[ Thu, Oct 27th 2011 ] - Market Wire
ICON Reports Q3 revenue growth of 7% to $241 mill .. f $431 million. (NASDAQ:ICLR) (ISIN:IE0005711209)
[ Thu, Oct 27th 2011 ] - Market Wire
Pfizer Receives European Approval to Extend Use o .. ars and Older for the Prevention of Invasive Pneu
Wed, October 26, 2011
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec oglasza pozytywne podsumowanie wynikw .. 3. badan nad doustnym BG-12 u pacjentw ze stward
[ Wed, Oct 26th 2011 ] - Market Wire
Stellar Biotechnologies &;; Life Diagno .. e Agreement for Stellar Brand KLH ELISA Test Kits
[ Wed, Oct 26th 2011 ] - Market Wire
2011 Third Quarter and Nine-Month Results
[ Wed, Oct 26th 2011 ] - Market Wire
Seattle Genetics Appoints Vice President, Medical .. nces Vice President, Quality Management Promotion
[ Wed, Oct 26th 2011 ] - Market Wire
Abiomed to Release New Protect II Data and Econom .. #59; Over 20 Impella Presentations Included i
[ Wed, Oct 26th 2011 ] - Market Wire
Health Canada Clears Immunovaccine for Ovarian Cancer Vaccine Trials
[ Wed, Oct 26th 2011 ] - Market Wire
Cytori to Webcast Third Quarter Financial Results November 3
[ Wed, Oct 26th 2011 ] - Market Wire
Magellan Health Services Joins with Share Our Strength to End Childhood Hunger in America
[ Wed, Oct 26th 2011 ] - Market Wire
Octapharma Locks-in Binding Forecast to Exceed $2M for ProMetic's Prion Capture Resin for H1 2012
[ Wed, Oct 26th 2011 ] - Market Wire
Amedisys Announces Third Quarter Earnings Release and Conference Call Date
[ Wed, Oct 26th 2011 ] - Market Wire
Covidien Launches Worldas First Non-Absorbable, Uni-Directional Knotless Suture
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec annonce des rsultats trs positifs l'i .. se 3 tudiant BG-12 (dimthylfumarate) administr pa
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec annuncia risultati preliminari positi .. ico di fase III del farmaco orale BG-12 (dimetilf
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec Announces Positive Top-Line Results f .. stigating Oral BG-12 (Dimethyl Fumarate) in Multi
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec meldet positive Topline-Ergebnisse au .. zur Prfung von oral verabreichtem BG-12 (Dimethyl
Tue, October 25, 2011
[ Tue, Oct 25th 2011 ] - Market Wire
Harwood Feffer LLP Announces Investigation of TranS1, Inc.
[ Tue, Oct 25th 2011 ] - Market Wire
West to Host 2011 Third Quarter Conference Call
[ Tue, Oct 25th 2011 ] - Market Wire
USANA Health Sciences Reports Third Quarter 2011 Financial Results
[ Tue, Oct 25th 2011 ] - Market Wire
Micro Imaging Technology Receives a Substantial Exclusive Licensing Proposal From EPIC Corporation
[ Tue, Oct 25th 2011 ] - Market Wire
Daniel Levangie Appointed to Insulet's Board of Directors
[ Tue, Oct 25th 2011 ] - Market Wire
The Law Firm of Levi &;; Korsinsky Noti .. Their Investment in K-V Pharmaceutical Company o
[ Tue, Oct 25th 2011 ] - Market Wire
VistaGen Therapeutics Reports Identification of C .. ts High-Yield Purification of Human Pluripotent S
[ Tue, Oct 25th 2011 ] - Market Wire
Amarantus BioSciences Appoints Dr. Owen Garrick as Strategic Advisor
[ Tue, Oct 25th 2011 ] - Market Wire
What's Ahead: Today's Economic Outlook - Equity R .. earch on Thoratec Corporation and C.R. Bard, Inc.
[ Tue, Oct 25th 2011 ] - Market Wire
Daxor Announces Filing of Patents for Total Body Albumin Analyzer
[ Tue, Oct 25th 2011 ] - Market Wire
OmniGuide Appoints Scott Flora as President & CEO
[ Tue, Oct 25th 2011 ] - Market Wire
ZYTO Corp Appoints Leading Experts to Scientific Advisory Board
[ Tue, Oct 25th 2011 ] - Market Wire
Gilead und GlobeImmune kndigen Lizenz- und Kooper .. klung therapeutischer Impfstoffe fr die Behandlun
[ Tue, Oct 25th 2011 ] - Market Wire
Gilead e GlobeImmune annunciano un contratto di l .. o sviluppo di vaccini terapeutici per il trattame
[ Tue, Oct 25th 2011 ] - Market Wire
Dr. Reddyas Q2 FY12 Financial Results

ProPhase Labs to Release Third Quarter Results on Wednesday, November 9th


//health-fitness.news-articles.net/content/2011/ .. d-quarter-results-on-wednesday-november-9th.html
Published in Health and Fitness on Wednesday, November 2nd 2011 at 5:39 GMT by Market Wire   Print publication without navigation


November 02, 2011 08:30 ET

ProPhase Labs to Release Third Quarter Results on Wednesday, November 9th

DOYLESTOWN, PA--(Marketwire - Nov 2, 2011) - ProPhase Labs (NASDAQ: [ PRPH ]) announced today that financial results for the third quarter, ended September 30, 2011, will be released before the market opens on Wednesday, November 9th. A shareholder's conference call will be held later that morning on November 9th, at 11:00am EST. ProPhase Labs Chairman and CEO, Ted Karkus, and COO/CFO Robert Cuddihy will provide a company overview including a review of activities and third quarter results. There will be a question and answer session following initial remarks.

The conference call will be webcast live at:
[ http://us.meeting-stream.com/prophaselabsinc_110911 ] at 11:00 AM (EST) on Wednesday, November 9, 2011.

Participants wishing to ask questions may access the live call by dialing (877) 217-6026 conference ID # 21014476. A replay of the conference call will be available for 90 days on the company website [ www.ProPhaseLabs.com ].

About ProPhase Labs

ProPhase Labs is a diversified natural health medical science company. It is a leading marketer and manufacturer of the Cold-EEZE® family of lozenges clinically proven to significantly reduce the severity and duration of the common cold. Cold-EEZE customers include leading national retailers, chain food, drug and mass merchandise stores, wholesalers and distributors, as well as independent pharmacies. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE lozenges and fulfill other contract manufacturing opportunities. ProPhase also owns 50% of Phusion Laboratories LLC ("Phusion"). Phusion licenses a revolutionary proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients or compounds. Phusion will formulate and test products to exploit market opportunities within ProPhase's robust OTC distribution channels. For more information visit us at [ www.ProPhaseLabs.com ].



Publication Contributing Sources